Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study

Diffuse large B-cell lymphoma (DLBCL) is a heterogenous group of diseases with various outcomes depending on the clinical and biological features. Optimal induction therapy for high-risk DLBCL is still unclear, and clinical trials are needed to evaluate alternative approaches. This study aimed to ev...

Full description

Bibliographic Details
Main Author: Dang, Chee Chean
Format: Thesis
Language:English
Published: 2018
Subjects:
Online Access:http://eprints.usm.my/43634/
Abstract Abstract here
_version_ 1854968005442666496
author Dang, Chee Chean
author_facet Dang, Chee Chean
author_sort Dang, Chee Chean
description Diffuse large B-cell lymphoma (DLBCL) is a heterogenous group of diseases with various outcomes depending on the clinical and biological features. Optimal induction therapy for high-risk DLBCL is still unclear, and clinical trials are needed to evaluate alternative approaches. This study aimed to evaluate the response rates and long term remission of induction therapy with addition of high dose methotrexate and cytarabine onto RCHOP for patients diagnosed with DLBCL. 62 DLBCL patients diagnosed between January 2011 to December 2014 were retrospectively analyzed.
first_indexed 2025-10-17T08:22:37Z
format Thesis
id usm-43634
institution Universiti Sains Malaysia
language English
last_indexed 2025-10-17T08:22:37Z
publishDate 2018
record_format eprints
record_pdf Abstract
spelling usm-436342019-04-12T05:24:48Z http://eprints.usm.my/43634/ Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study Dang, Chee Chean RS1-441 Pharmacy and materia medica Diffuse large B-cell lymphoma (DLBCL) is a heterogenous group of diseases with various outcomes depending on the clinical and biological features. Optimal induction therapy for high-risk DLBCL is still unclear, and clinical trials are needed to evaluate alternative approaches. This study aimed to evaluate the response rates and long term remission of induction therapy with addition of high dose methotrexate and cytarabine onto RCHOP for patients diagnosed with DLBCL. 62 DLBCL patients diagnosed between January 2011 to December 2014 were retrospectively analyzed. 2018-07 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/43634/1/DANG%20CHEE%20CHEAN.pdf Dang, Chee Chean (2018) Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study. Masters thesis, Universiti Sains Malaysia.
spellingShingle RS1-441 Pharmacy and materia medica
Dang, Chee Chean
Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
title Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
title_full Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
title_fullStr Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
title_full_unstemmed Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
title_short Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
title_sort clinical outcomes of induction therapywith addition of high dose methotrexate and cytarabine to existing standard treatment in patients with newly diagnosed diffused large b cell lymphoma a retrospective study
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/43634/
work_keys_str_mv AT dangcheechean clinicaloutcomesofinductiontherapywithadditionofhighdosemethotrexateandcytarabinetoexistingstandardtreatmentinpatientswithnewlydiagnoseddiffusedlargebcelllymphomaaretrospectivestudy